This is a table of type proper and their frequencies. Use it to search & browse the list to learn more about your study carrel.
| proper | frequency |
|---|---|
| COVID-19 | 584 |
| SARS | 321 |
| CoV-2 | 244 |
| BMI | 239 |
| ACE2 | 101 |
| Obesity | 89 |
| Health | 79 |
| China | 75 |
| RNA | 66 |
| • | 61 |
| States | 59 |
| United | 58 |
| IL-6 | 51 |
| Association | 51 |
| ICU | 48 |
| OBEDIS | 47 |
| H1N1 | 46 |
| Coronavirus | 43 |
| Wuhan | 42 |
| TNF | 41 |
| Study | 41 |
| CVD | 41 |
| Disease | 39 |
| meta | 38 |
| New | 34 |
| EASO | 34 |
| T | 33 |
| RAAS | 32 |
| PA | 32 |
| Food | 32 |
| Risk | 31 |
| II | 31 |
| US | 30 |
| NAFLD | 30 |
| York | 30 |
| α | 30 |
| World | 26 |
| sha | 25 |
| Covid-19 | 25 |
| circRNAs | 24 |
| Organization | 24 |
| kg | 23 |
| Program | 23 |
| OB | 23 |
| City | 23 |
| Nutrition | 22 |
| DOI | 22 |
| Clinical | 21 |
| IR | 21 |
| National | 20 |
| M | 20 |
| J | 20 |
| Influenza | 20 |
| Care | 20 |
| Body | 20 |
| Adipose | 20 |
| Europe | 19 |
| ARDS | 19 |
| ACE-2 | 19 |
| A | 18 |
| UK | 18 |
| European | 18 |
| Weight | 17 |
| USA | 17 |
| Prevention | 17 |
| Control | 17 |
| Healthy | 16 |
| Adults | 16 |
| CI | 16 |
| Childhood | 16 |
| Circular | 16 |
| IL-1 | 16 |
| Outcomes | 16 |
| Patients | 16 |
| Management | 16 |
| WIC | 16 |
| COVID‐19 | 15 |
| Italy | 15 |
| CD4 | 15 |
| Group | 15 |
| Pandemic | 15 |
| Silver | 15 |
| Spring | 15 |
| miRNA | 15 |
| OSA | 14 |
| Impact | 14 |
| IL-10 | 14 |
| Human | 14 |
| Fig | 14 |
| CoV | 14 |
| American | 14 |
| COPD | 13 |
| COVID | 13 |
| Characteristics | 13 |
| Ang | 13 |
| Americans | 13 |
| CRP | 13 |
| CD8 | 13 |
| Children | 13 |
| Data | 13 |
| France | 13 |
| miRNAs | 13 |
| Review | 13 |
| T2DM | 13 |
| Committee | 13 |
| LPS | 12 |
| Angiotensin | 12 |
| Diabetes | 12 |
| Global | 12 |
| Insulin | 12 |
| MCP-1 | 12 |
| MyPlate | 12 |
| Research | 12 |
| Table | 12 |
| WAT | 12 |
| ncRNAs | 12 |
| peptide-1 | 12 |
| Intensive | 11 |
| April | 11 |
| Article | 11 |
| C | 11 |
| COV-2 | 11 |
| D | 11 |
| EE | 11 |
| Immune | 11 |
| GLP1 | 11 |
| March | 11 |
| NASH | 11 |
| monocyte | 11 |
| Obes | 11 |
| SB | 11 |
| School | 11 |
| TLR4 | 11 |
| Tissue | 11 |
| Y | 11 |
| Accepted | 10 |
| Child | 10 |
| Development | 10 |
| Diet | 10 |
| Effect | 10 |
| ICD-10 | 10 |
| MERS | 10 |
| N | 10 |
| Paris | 10 |
| RAS | 10 |
| System | 10 |
| Zhang | 10 |
| adipogenesis | 10 |
| mass | 10 |
| Assessment | 9 |
| Center | 9 |
| Quality | 9 |
| Epidemiology | 9 |
| Heart | 9 |
| L. | 9 |
| Liver | 9 |
| Medical | 9 |
| Metabolic | 9 |
| Virus | 9 |
| Report | 9 |
| Services | 9 |
| State | 9 |
| Supplementary | 9 |
| Treatment | 9 |
| U.S. | 9 |
| WHO | 9 |
| circRNA | 9 |
| Infection | 8 |
| Guidelines | 8 |
| Factors | 8 |
| Activation | 8 |
| DPP4 | 8 |
| CoV2 | 8 |
| Assistance | 8 |
| M. | 8 |
| Loss | 8 |
| Department | 8 |
| Mechanisms | 8 |
| Seattle | 8 |
| Meta | 8 |
| Use | 8 |
| Syndrome | 8 |
| oro | 8 |
| Renin | 8 |
| QoL | 8 |
| Pediatric | 8 |
| Novel | 8 |
| Expert | 7 |
| J. | 7 |
| International | 7 |
| Ill | 7 |
| IFN | 7 |
| I | 7 |
| Hospital | 7 |
| Force | 7 |
| BMR | 7 |
| DXA | 7 |
| DHA | 7 |
| Cohort | 7 |
| Cardiovascular | 7 |
| Arabia | 7 |
| Analysis | 7 |
| Adipocyte | 7 |
| Mass | 7 |
| Kingdom | 7 |
| Region | 7 |
| Mexico | 7 |
| VD | 7 |
| Overweight | 7 |
| m² | 7 |
| mRNA | 7 |
| lncRNAs | 7 |
| inflammasome | 7 |
| chemoattractant | 7 |
| body | 7 |
| metformin | 7 |
| Trial | 7 |
| Task | 7 |
| Saudi | 7 |
| Respiratory | 7 |
| Resistance | 7 |
| ≥ | 7 |
| Pathophysiology | 7 |
| TriNetX | 7 |
| Hydroxychloroquine | 6 |
| Diseases | 6 |
| EQ-5D-5L | 6 |
| Early | 6 |
| Factor | 6 |
| February | 6 |
| HP | 6 |
| Interventions | 6 |
| IMV | 6 |
| India | 6 |
| Insecurity | 6 |
| January | 6 |
| Lung | 6 |
| D. | 6 |
| December | 6 |
| Area | 6 |
| Commission | 6 |
| Chronic | 6 |
| Chloroquine | 6 |
| CT | 6 |
| CRF | 6 |
| CORONADO | 6 |
| Brazil | 6 |
| Based | 6 |
| Macrophage | 6 |
| Adult | 6 |
| Adiposity | 6 |
| Adiponectin | 6 |
| Academy | 6 |
| AP | 6 |
| ANRIL | 6 |
| M1 | 6 |
| Index | 6 |
| OR | 6 |
| interleukin-6 | 6 |
| USDA | 6 |
| VA | 6 |
| Viral | 6 |
| YMCA | 6 |
| disease | 6 |
| infuenza | 6 |
| m2 | 6 |
| Treg | 6 |
| nan | 6 |
| protein-1 | 6 |
| tocilizumab | 6 |
| ± | 6 |
| Observational | 6 |
| ␣ | 6 |
| Type | 6 |
| − | 6 |
| Th17 | 6 |
| ROBINS | 6 |
| Taste | 6 |
| Pediatr | 6 |
| Peru | 6 |
| Project | 6 |
| RD | 6 |
| Pathogenesis | 6 |
| RTI | 6 |
| Society | 6 |
| Stefano | 6 |
| Systematic | 6 |
| TMPRSS2 | 6 |
| Retrospective | 6 |
| Healthcare | 5 |
| Figure | 5 |
| Front | 5 |
| Frühbeck | 5 |
| H. | 5 |
| HCO | 5 |
| I. | 5 |
| Hospitalized | 5 |
| Independent | 5 |
| Korea | 5 |
| Li | 5 |
| Eating | 5 |
| Lille | 5 |
| Life | 5 |
| California | 5 |
| Critical | 5 |
| Core | 5 |
| Comorbidities | 5 |
| Cochrane | 5 |
| CoV-1 | 5 |
| Chinese | 5 |
| CDR1as | 5 |
| Breakfast | 5 |
| BIC | 5 |
| Associated | 5 |
| America | 5 |
| Airway | 5 |
| Administration | 5 |
| A. | 5 |
| MAFLD | 5 |
| Liu | 5 |
| Response | 5 |
| Maria | 5 |
| Service | 5 |
| May | 5 |
|  | 5 |
| health | 5 |
| en | 5 |
| ciRNAs | 5 |
| browning | 5 |
| Young | 5 |
| Washington | 5 |
| University | 5 |
| Unit | 5 |
| Th2 | 5 |
| Teen | 5 |
| TNF- | 5 |
| Sleep | 5 |
| exonic | 5 |
| SBP | 5 |
| OpenSAFELY | 5 |
| RBPs | 5 |
| Metab | 5 |
| Mice | 5 |
| Model | 5 |
| Mortality | 5 |
| Medicine | 5 |
| PCR | 5 |
| Public | 5 |
| Pulmonary | 5 |
| PSM | 5 |
| Med | 5 |
| Protein | 5 |
| FFQ | 4 |
| EDS | 4 |
| EHR | 4 |
| EIciRNAs | 4 |
| ECG | 4 |
| Effectiveness | 4 |
| Electronic | 4 |
| Endocrinol | 4 |
| Evaluation | 4 |
| Executive | 4 |
| Expression | 4 |
| EPA | 4 |
| H19 | 4 |
| Farpour | 4 |
| Fat | 4 |
| Features | 4 |
| Fisher | 4 |
| Goossens | 4 |
| HbA | 4 |
| Household | 4 |
| ICUs | 4 |
| ID-19 | 4 |
| IL-4 | 4 |
| IL-8 | 4 |
| Dysfunction | 4 |
| E | 4 |
| CPT | 4 |
| Dutch | 4 |
| Diagnostic | 4 |
| Inflammation | 4 |
| /m | 4 |
| ABCD | 4 |
| ACE | 4 |
| ADAMTS13 | 4 |
| Agriculture | 4 |
| Aldosterone | 4 |
| ApoE | 4 |
| B | 4 |
| Biobank | 4 |
| COV | 4 |
| Centers | 4 |
| Chicago | 4 |
| Clin | 4 |
| Czernichow | 4 |
| DCs | 4 |
| DIC | 4 |
| DM | 4 |
| DSS | 4 |
| David | 4 |
| Del | 4 |
| DiaRem | 4 |
| Diagnosis | 4 |
| Immunometabolism | 4 |
| Bariatric | 4 |
| Inhibitors | 4 |
| White | 4 |
| Series | 4 |
| Severity | 4 |
| Shenzhen | 4 |
| South | 4 |
| Supplemental | 4 |
| Surgery | 4 |
| Syndr | 4 |
| TNF- | 4 |
| USFDA | 4 |
| VC | 4 |
| Ventilation | 4 |
| Women | 4 |
| SGLT-2 | 4 |
| X | 4 |
| Xue | 4 |
| ≥40 | 4 |
| circANRIL | 4 |
| emon | 4 |
| hypovitaminosis | 4 |
| naso | 4 |
| orlistat | 4 |
| p= | 4 |
| steatohepatitis | 4 |
| Interaction | 4 |
| Security | 4 |
| vivo | 4 |
| S | 4 |
| Network | 4 |
| Receptor | 4 |
| JAK1 | 4 |
| JAK2 | 4 |
| Jiangsu | 4 |
| Joint | 4 |
| Kurbo | 4 |
| Lambert | 4 |
| Lombardy | 4 |
| Molina | 4 |
| NFL | 4 |
| NLRP3 | 4 |
| Middle | 4 |
| ONS | 4 |
| Obstructive | 4 |
| Pok | 4 |
| RT | 4 |
| Position | 4 |
| Potential | 4 |
| Practice | 4 |
| Prediction | 4 |
| Presenting | 4 |
| Questionnaire | 4 |
| Obama | 4 |
| R | 4 |
| Gema | 3 |
| Future | 3 |
| GLP-1 | 3 |
| GM | 3 |
| Glycemic | 3 |
| General | 3 |
| Gijs | 3 |
| Glucagon | 3 |
| Glucose | 3 |
| French | 3 |
| Functions | 3 |
| East | 3 |
| First | 3 |
| Findings | 3 |
| Fatty | 3 |
| Fang | 3 |
| Exosome | 3 |
| Exosomal | 3 |
| Evidence | 3 |
| Epidemic | 3 |
| Endotracheal | 3 |
| Edmonton | 3 |
| EcircRNAs | 3 |
| HFD | 3 |
| Gut | 3 |
| Intervention | 3 |
| Holm | 3 |
| Hospitalization | 3 |
| E. | 3 |
| MCP1 | 3 |
| MAS | 3 |
| Lipid | 3 |
| Leptin | 3 |
| Laura | 3 |
| Lancet | 3 |
| LOINC | 3 |
| Kong | 3 |
| Kaplan | 3 |
| KSRP | 3 |
| K. | 3 |
| JPED | 3 |
| Iran | 3 |
| Initiative | 3 |
| Inflammasome | 3 |
| Infections | 3 |
| Improvement | 3 |
| ISARIC | 3 |
| IL6 | 3 |
| IL-2 | 3 |
| IL-12 | 3 |
| ICNARC | 3 |
| EOSS | 3 |
| CAAT | 3 |
| Dr | 3 |
| Director | 3 |
| Burden | 3 |
| Browning | 3 |
| Blood | 3 |
| Biomarker | 3 |
| Binding | 3 |
| Berlin | 3 |
| Baseline | 3 |
| Arkansas | 3 |
| Andrea | 3 |
| Alligier | 3 |
| Aggarwal | 3 |
| Agency | 3 |
| Adolescent | 3 |
| Adipocytes | 3 |
| Activity | 3 |
| ASMBA | 3 |
| ASJ | 3 |
| APHP | 3 |
| A1c | 3 |
| A(H1N1 | 3 |
| > | 3 |
| 8) | 3 |
| -Case | 3 |
| Busetto | 3 |
| Martin | 3 |
| CBT | 3 |
| Collaborators | 3 |
| Dietetics | 3 |
| Dietary | 3 |
| Dicker | 3 |
| Cytokine | 3 |
| Curr | 3 |
| Cross | 3 |
| Critically | 3 |
| Covid | 3 |
| Complications | 3 |
| Complement | 3 |
| Collaboration | 3 |
| CC | 3 |
| Clément | 3 |
| Classification | 3 |
| Chen | 3 |
| Centres | 3 |
| CPAP | 3 |
| COVID19 | 3 |
| CDC | 3 |
| CD4ϩ | 3 |
| CD26 | 3 |
| CCL2 | 3 |
| MIST | 3 |
| BIA | 3 |
| Massachusetts | 3 |
| Zhao | 3 |
| Youth | 3 |
| Yadav | 3 |
| Wound | 3 |
| Working | 3 |
| Woodward | 3 |
| WOMAC | 3 |
| Version | 3 |
| Vascular | 3 |
| VO | 3 |
| V. | 3 |
| USPSTF | 3 |
| U | 3 |
| Trials | 3 |
| Tocilizumab | 3 |
| Therapy | 3 |
| Th1 | 3 |
| TRIAD | 3 |
| TNFα | 3 |
| Systems | 3 |
| Survey | 3 |
| Surveillance | 3 |
| Summit | 3 |
| Summer | 3 |
| ZNF609 | 3 |
| anakinra | 3 |
| Staging | 3 |
| cardiometabolic | 3 |
| Maternal | 3 |
| γ | 3 |
| β | 3 |
| sistema | 3 |
| series | 3 |
| pyrin | 3 |
| omentin | 3 |
| noncoding | 3 |
| multiorgan | 3 |
| multicentre | 3 |
| microRNAs | 3 |
| miR-133 | 3 |
| medRxiv | 3 |
| max | 3 |
| mRNAs | 3 |
| m(2 | 3 |
| lymphopenia | 3 |
| hyperinflammatory | 3 |
| hydroxychloroquine | 3 |
| exosomal | 3 |
| cortex | 3 |
| circSAMD4A | 3 |
| catenin | 3 |
| Steatohepatitis | 3 |
| Zhu | 3 |
| Smell | 3 |
| Pre | 3 |
| Pol | 3 |
| Pilot | 3 |
| Physiol | 3 |
| Patel | 3 |
| Participation | 3 |
| PLS | 3 |
| PGE2 | 3 |
| PGE | 3 |
| Nutritional | 3 |
| Nonalcoholic | 3 |
| Neck | 3 |
| Natural | 3 |
| Nathalie | 3 |
| Na | 3 |
| NF | 3 |
| Mycobacterium | 3 |
| Mullerova | 3 |
| Monocyte | 3 |
| Metropolitan | 3 |
| Mellitus | 3 |
| Meier | 3 |
| Sleeve | 3 |
| Mechanical | 3 |
| Population | 3 |
| Non | 3 |
| SPSS | 3 |
| Roux | 3 |
| Singh | 3 |
| Singapore | 3 |
| Preventive | 3 |
| Severe | 3 |
| Sendai | 3 |
| Scientific | 3 |
| Sandeep | 3 |
| STOP | 3 |
| SOS | 3 |
| SL | 3 |
| S. | 3 |
| SC | 3 |
| Rosuvastatin | 3 |
| Roche | 3 |
| Remdesivir | 3 |
| Randomized | 3 |
| Rakhee | 3 |
| RR | 3 |
| RBP | 3 |
| Publique | 3 |
| PubMed | 3 |
| Programs | 3 |
| HPA | 2 |
| H | 2 |
| HOMA | 2 |
| HLH | 2 |
| HDHL | 2 |
| H5N1 | 2 |
| Hussain | 2 |
| Guideline | 2 |
| Guide | 2 |
| Germany | 2 |
| HRSA | 2 |
| Genome | 2 |
| HPLC | 2 |
| Huang | 2 |
| Halford | 2 |
| HbA1c | 2 |
| Hebebrand | 2 |
| Helsinki | 2 |
| High | 2 |
| Hong | 2 |
| Hopkins | 2 |
| Host | 2 |
| Hu | 2 |
| HuR | 2 |
| Hunger | 2 |
| Gastrectomy | 2 |
| Geneva | 2 |
| Education | 2 |
| Gain | 2 |
| GWAS | 2 |
| ICD-9-CM | 2 |
| EMC | 2 |
| EPIC | 2 |
| Elementary | 2 |
| Eleni | 2 |
| Emergency | 2 |
| Emerging | 2 |
| Endothelial | 2 |
| Energy | 2 |
| England | 2 |
| English | 2 |
| Ethics | 2 |
| Euan | 2 |
| Examination | 2 |
| FFAs | 2 |
| FGF10 | 2 |
| FIB-4 | 2 |
| FR | 2 |
| Fasn | 2 |
| Fibrosis | 2 |
| Firmicutes | 2 |
| Focus | 2 |
| Framingham | 2 |
| Function | 2 |
| G. | 2 |
| ICD-10-CM | 2 |
| Lighter | 2 |
| ICMR | 2 |
| Lane | 2 |
| K | 2 |
| Kaźmierczak | 2 |
| Khan | 2 |
| Kids | 2 |
| Krela | 2 |
| Kristina | 2 |
| L | 2 |
| LDH | 2 |
| LINC | 2 |
| LV | 2 |
| Laboratory | 2 |
| Lady | 2 |
| Langin | 2 |
| III | 2 |
| Laparoscopic | 2 |
| Lausanne | 2 |
| Laville | 2 |
| Lerman | 2 |
| Letter | 2 |
| Lifestyle | 2 |
| ECPO | 2 |
| Liraglutide | 2 |
| Listeria | 2 |
| Lockhart | 2 |
| Long | 2 |
| Low | 2 |
| Julia | 2 |
| Johnson | 2 |
| Jens | 2 |
| Jason | 2 |
| IL-13 | 2 |
| IL-1 | 2 |
| IL-7 | 2 |
| INK4 | 2 |
| IQR | 2 |
| IRB | 2 |
| IV | 2 |
| IgA | 2 |
| Imaging | 2 |
| Immunity | 2 |
| Immunol | 2 |
| Immunological | 2 |
| Increased | 2 |
| Induced | 2 |
| Infants | 2 |
| Infectious | 2 |
| Inflammatory | 2 |
| Information | 2 |
| Institute | 2 |
| Interleukin-1 | 2 |
| Interleukin-6 | 2 |
| Intestinal | 2 |
| Invasive | 2 |
| JAK | 2 |
| JPI | 2 |
| EMBASE | 2 |
| Case | 2 |
| EASD | 2 |
| Apnea | 2 |
| Archna | 2 |
| Arcinas | 2 |
| Asian | 2 |
| Asians | 2 |
| Attribution | 2 |
| Audit | 2 |
| BCG | 2 |
| BOD | 2 |
| Bacteroidetes | 2 |
| Baker | 2 |
| Barak | 2 |
| Behavioral | 2 |
| Benefits | 2 |
| Bonferroni | 2 |
| Bouwman | 2 |
| Box | 2 |
| Brain | 2 |
| Bubalus | 2 |
| Buffalo | 2 |
| Bypass | 2 |
| C.G. | 2 |
| CACFP | 2 |
| CARDIA | 2 |
| CCL4 | 2 |
| CD83 | 2 |
| Approach | 2 |
| Anthropometry | 2 |
| CDR | 2 |
| Ang-(1 | 2 |
| Lunch | 2 |
| 1c | 2 |
| 3a | 2 |
| 6-min | 2 |
| < | 2 |
| ADVANCE | 2 |
| AIIMS | 2 |
| ALU | 2 |
| AMPK | 2 |
| AOUP | 2 |
| ARB | 2 |
| Act | 2 |
| Action | 2 |
| Acute | 2 |
| Adaptive | 2 |
| Admission | 2 |
| Adolesc | 2 |
| Age | 2 |
| Agnieszka | 2 |
| Agostino | 2 |
| Ahmet | 2 |
| Alberto | 2 |
| Alliance | 2 |
| Alveolar | 2 |
| Amplification | 2 |
| CDK2 | 2 |
| CNS | 2 |
| E66 | 2 |
| Controlled | 2 |
| Cov-2 | 2 |
| Covid19-APHP | 2 |
| Creative | 2 |
| Criteria | 2 |
| Cummings | 2 |
| Cunha | 2 |
| DBT | 2 |
| DNA | 2 |
| DVC | 2 |
| Dana | 2 |
| De | 2 |
| Declaration | 2 |
| Designated | 2 |
| Detection | 2 |
| Detroit | 2 |
| DiaBetter | 2 |
| Diego | 2 |
| Differentiation | 2 |
| Disorders | 2 |
| Distinct | 2 |
| Distress | 2 |
| Diverse | 2 |
| Division | 2 |
| Dror | 2 |
| Drug | 2 |
| Correlation | 2 |
| Contribution | 2 |
| CODAM | 2 |
| Consortium | 2 |
| Cai | 2 |
| Cambridge | 2 |
| Campbell | 2 |
| Canada | 2 |
| Cancer | 2 |
| Cells | 2 |
| Cemal | 2 |
| Challenge | 2 |
| Chantal | 2 |
| Characterisation | 2 |
| Chemokine | 2 |
| Chester | 2 |
| Chi | 2 |
| Chile | 2 |
| ChooseMyPlate | 2 |
| Ciampo | 2 |
| Circ | 2 |
| Claire | 2 |
| CoV-2-RAAS | 2 |
| Cohen | 2 |
| College | 2 |
| Commons | 2 |
| Communities | 2 |
| Composition | 2 |
| Consensus | 2 |
| Luc | 2 |
| Dependent | 2 |
| MA | 2 |
| Wang | 2 |
| USP7 | 2 |
| Underweight | 2 |
| Utilization | 2 |
| VE | 2 |
| VID-19 | 2 |
| Varga | 2 |
| Variables | 2 |
| Verona | 2 |
| Vesicles | 2 |
| Via | 2 |
| Virdis | 2 |
| Viroporin | 2 |
| Ward | 2 |
| Speciality | 2 |
| Western | 2 |
| Whitney | 2 |
| Wins | 2 |
| Wnt | 2 |
| Wu | 2 |
| X. | 2 |
| Xpert | 2 |
| Xpress | 2 |
| YY | 2 |
| Year | 2 |
| Z. | 2 |
| Zhejiang | 2 |
| U.S | 2 |
| Trust | 2 |
| Trends | 2 |
| Translation | 2 |
| Spread | 2 |
| Standards | 2 |
| Statement | 2 |
| Status | 2 |
| Steatosis | 2 |
| Stephanie | 2 |
| Stephen | 2 |
| Structure | 2 |
| Studies | 2 |
| Summary | 2 |
| Surg | 2 |
| Surveys | 2 |
| Survival | 2 |
| THP-1 | 2 |
| TM | 2 |
| TRAF3 | 2 |
| Tables | 2 |
| Taddei | 2 |
| Tappy | 2 |
| Target | 2 |
| Term | 2 |
| Therapeutic | 2 |
| Thrombotic | 2 |
| Timur | 2 |
| Transcript | 2 |
| Zheng | 2 |
| adipokines | 2 |
| analysis | 2 |
| hypercytokinemia | 2 |
| hyperresponsiveness | 2 |
| hypoventilation | 2 |
| inhibitor-1 | 2 |
| interindividual | 2 |
| kappaB | 2 |
| key | 2 |
| liraglutide | 2 |
| lymphohistiocytosis | 2 |
| miR-7 | 2 |
| microRNA | 2 |
| mmHg | 2 |
| ob | 2 |
| p=0.01 | 2 |
| pH | 2 |
| pre | 2 |
| review | 2 |
| selectin | 2 |
| sitagliptin | 2 |
| study | 2 |
| sustentacular | 2 |
| visfatin | 2 |
| κB | 2 |
| Ͼ | 2 |
| ≥35 | 2 |
| MEDLINE | 2 |
| hyperglycaemia | 2 |
| hydroxy)chloroquine | 2 |
| angiotensinogen | 2 |
| hepcidin | 2 |
| betacoronavirus | 2 |
| bitartrate | 2 |
| bubalis | 2 |
| caspase-1 | 2 |
| circArhgap5 | 2 |
| circNrxn2 | 2 |
| colchicine | 2 |
| committee | 2 |
| coronavirus-2 | 2 |
| cotransporter | 2 |
| covid-19 | 2 |
| cox | 2 |
| cysteamine | 2 |
| da | 2 |
| data | 2 |
| db | 2 |
| doc_id | 2 |
| endothelin-1 | 2 |
| enzyme-2 | 2 |
| exendin-4 | 2 |
| expiratory | 2 |
| express | 2 |
| federated | 2 |
| glomerulopathy | 2 |
| height | 2 |
| Specificities | 2 |
| Z | 2 |
| Soremartec | 2 |
| Ordinal | 2 |
| Neovius | 2 |
| Neurological | 2 |
| Norfolk | 2 |
| Northwell | 2 |
| Nutr | 2 |
| Nutrición | 2 |
| O'Shea | 2 |
| OBEsity | 2 |
| Obese | 2 |
| Observatory | 2 |
| Office | 2 |
| Olfactory | 2 |
| Otolaryngol.-Head | 2 |
| Pediatrics | 2 |
| Overview | 2 |
| P<0.001 | 2 |
| PAI-1 | 2 |
| PINT | 2 |
| POD | 2 |
| POWER | 2 |
| PRDM16 | 2 |
| PRISMA | 2 |
| PSPC1 | 2 |
| PSS | 2 |
| Parent | 2 |
| Paul | 2 |
| Nannipieri | 2 |
| NSLP | 2 |
| NOD | 2 |
| NLP | 2 |
| MICRA | 2 |
| Situation | 2 |
| MIP1 | 2 |
| MOH | 2 |
| Manca | 2 |
| Mann | 2 |
| Marco | 2 |
| Martimbianco | 2 |
| Masi | 2 |
| Material | 2 |
| Measurement | 2 |
| Media | 2 |
| Metabolome | 2 |
| Metformin | 2 |
| Michelle | 2 |
| MicroRNAs | 2 |
| Microbiota | 2 |
| Ministry | 2 |
| Modulator | 2 |
| Monica | 2 |
| Moriconi | 2 |
| Multivariate | 2 |
| NB | 2 |
| NFS | 2 |
| NHS | 2 |
| Pazarlı | 2 |
| Noncoding | 2 |
| Perceived | 2 |
| MET | 2 |
| RNAs | 2 |
| ROS | 2 |
| Rachel | 2 |
| Radiology | 2 |
| Rapid | 2 |
| Rebelos | 2 |
| Recent | 2 |
| Related | 2 |
| Res | 2 |
| Reservoir | 2 |
| Rev | 2 |
| Reviews | 2 |
| Riera | 2 |
| RDN | 2 |
| SAB | 2 |
| SARS‐CoV‐2 | 2 |
| SR | 2 |
| Salvatore | 2 |
| Scale | 2 |
| Sci | 2 |
| Sectional | 2 |
| Sensitivity | 2 |
| Sepsis | 2 |
| Septic | 2 |
| Peres | 2 |
| Signaling | 2 |
| RECORD | 2 |
| Shock | 2 |
| RCTs | 2 |
| Preoperative | 2 |
| RANTES | 2 |
| Petrilli | 2 |
| Phenotype | 2 |
| Philip | 2 |
| Physical | 2 |
| Play | 2 |
| Pneumonia | 2 |
| Poor | 2 |
| Poverty | 2 |
| Prato | 2 |
| Predictors | 2 |
| Pregnancy | 2 |
| Personalized | 2 |
| President | 2 |
| Prevalence | 2 |
| Prices | 2 |
| Probl | 2 |
| Programming | 2 |
| Prospective | 2 |
| Protection | 2 |
| Protective | 2 |
| Proteins | 2 |
| Protocol | 2 |
| Pressure | 2 |
| HIF1an | 1 |
| HIPPA | 1 |
| HIP | 1 |
| HIF | 1 |
| HCoV | 1 |
| HIF-1alpha | 1 |
| HHS | 1 |
| HDLcholesterol | 1 |
| HDL | 1 |
| HR | 1 |
| HCL | 1 |
| HL7 | 1 |
| Haig | 1 |
| HRCR | 1 |
| Habits | 1 |
| Habitus | 1 |
| Hager | 1 |
| Haiyan | 1 |
| Hammarstrom | 1 |
| Handbook | 1 |
| Handicaps | 1 |
| Handjieva | 1 |
| Hannele | 1 |
| Hans | 1 |
| H904 | 1 |
| Harry | 1 |
| HCC | 1 |
| Gralinski | 1 |
| H1N1pdm | 1 |
| H1H1 | 1 |
| Hartman | 1 |
| George | 1 |
| Geriatrics | 1 |
| Gerontology | 1 |
| Gerry | 1 |
| Gformula | 1 |
| Ghassan | 1 |
| Glycaemic | 1 |
| Glycolysis | 1 |
| Glycosylated | 1 |
| Golan | 1 |
| Good | 1 |
| 1 | |
| Grace | 1 |
| Grailer | 1 |
| Genomic | 1 |
| Gramnegative | 1 |
| Greater | 1 |
| Growth | 1 |
| Guan | 1 |
| Guang | 1 |
| Guerot | 1 |
| Guidance | 1 |
| Gursimran | 1 |
| Gutiérrez‐Ortiz | 1 |
| Harshitha | 1 |
| IGT | 1 |
| Harveian | 1 |
| Hypotheses | 1 |
| Huebner | 1 |
| Huizinga | 1 |
| Hulot | 1 |
| Hydroxymethylglutaryl | 1 |
| Hyper | 1 |
| Hyperant | 1 |
| Hyperinflammatory | 1 |
| Hyperinsulinemia | 1 |
| Hyperinsulinemic | 1 |
| Hyperleptinemia | 1 |
| Hyperlipidemic | 1 |
| Hyposmia | 1 |
| Hypoxaemia | 1 |
| Hasani | 1 |
| I.A. | 1 |
| I10 | 1 |
| I50 | 1 |
| IAGG | 1 |
| IBM | 1 |
| ICD | 1 |
| ICD-11 | 1 |
| ICD-9 | 1 |
| ICH-1 | 1 |
| IGF2 | 1 |
| Genetics | 1 |
| II)/type | 1 |
| Hubei | 1 |
| Huaping | 1 |
| House | 1 |
| Honk | 1 |
| Hassapidou | 1 |
| Hassink | 1 |
| Hauner | 1 |
| HbA1C | 1 |
| Heathy | 1 |
| Hee | 1 |
| Helen | 1 |
| Hematopoietic | 1 |
| Hemisphere | 1 |
| Hemodynamic | 1 |
| Hemoglobin | 1 |
| Hepatic | 1 |
| Hepatitis | 1 |
| Hepatoxicity | 1 |
| Heritability | 1 |
| Heterogeneity | 1 |
| Heterogeniety | 1 |
| Hichami | 1 |
| Higher | 1 |
| Hispanics | 1 |
| Histopathology | 1 |
| Historical | 1 |
| Home | 1 |
| Homeostasis | 1 |
| Homeostatic | 1 |
| Genomewide | 1 |
| Eligible | 1 |
| Genetic | 1 |
| FBG | 1 |
| Evaluating | 1 |
| Ewa | 1 |
| Exenatide | 1 |
| Exercise | 1 |
| Exhaustion | 1 |
| Exon | 1 |
| Expansion | 1 |
| Expenditure | 1 |
| Experience | 1 |
| Exposure | 1 |
| Extracellular | 1 |
| F. | 1 |
| FDA | 1 |
| Genet | 1 |
| FEMA | 1 |
| FEV | 1 |
| FEV1 | 1 |
| FIGO | 1 |
| FP | 1 |
| FRC | 1 |
| FTO | 1 |
| FVC | 1 |
| 1 | |
| Faienza | 1 |
| Failure | 1 |
| Fairbrother | 1 |
| Europeans | 1 |
| EuroQol | 1 |
| Eun | 1 |
| Etiology | 1 |
| Elena | 1 |
| IL | 1 |
| Ellen | 1 |
| Elmaogullari | 1 |
| Embolism | 1 |
| Emilio | 1 |
| Emily | 1 |
| Emmanouil | 1 |
| Emmanuel | 1 |
| Emotional | 1 |
| Employment | 1 |
| Endocrinology | 1 |
| Endoscopic | 1 |
| Endothelialitis | 1 |
| Endotoxin | 1 |
| Entry | 1 |
| Enzyme | 1 |
| Epicentro | 1 |
| Epidemiologic | 1 |
| Epidemiological | 1 |
| Epigenetics | 1 |
| Epworth | 1 |
| Erica | 1 |
| Ethical | 1 |
| Ethicon | 1 |
| Families | 1 |
| Farooqi | 1 |
| Favor | 1 |
| Fábio | 1 |
| G473 | 1 |
| GA | 1 |
| GBD | 1 |
| GC | 1 |
| GERD | 1 |
| GGT | 1 |
| GHO | 1 |
| GI | 1 |
| GLP-1RA | 1 |
| GLP-1RAs | 1 |
| GRAVITAS | 1 |
| GTPase | 1 |
| Ga | 1 |
| Gaal | 1 |
| Gabriele | 1 |
| Gabrielle | 1 |
| Gao | 1 |
| Garg | 1 |
| Gastroenterology | 1 |
| Gattinoni | 1 |
| Gautier | 1 |
| Geltrude | 1 |
| Gene | 1 |
| Generation | 1 |
| Genes | 1 |
| G.H. | 1 |
| Freedman | 1 |
| Federal | 1 |
| Free | 1 |
| Feelin | 1 |
| Feinstein | 1 |
| Felicia | 1 |
| Fermecutes | 1 |
| Ferraz | 1 |
| Fetal | 1 |
| Fi02 | 1 |
| FiSK | 1 |
| Figlia | 1 |
| File | 1 |
| Final | 1 |
| Fiscal | 1 |
| Fitness | 1 |
| FitnessGram | 1 |
| Florida | 1 |
| Football | 1 |
| Forms | 1 |
| Foteini | 1 |
| Foundation | 1 |
| Foundations | 1 |
| Foxo3 | 1 |
| Francesco | 1 |
| Francisca | 1 |
| Frank | 1 |
| François | 1 |
| IIV3 | 1 |
| Järvinen | 1 |
| IL-13Rα | 1 |
| Language | 1 |
| LICORN | 1 |
| LIPGENE | 1 |
| LMPG | 1 |
| LNC | 1 |
| LW | 1 |
| LXR | 1 |
| La | 1 |
| Lack | 1 |
| Laiwu | 1 |
| Lambadiari | 1 |
| Lammert | 1 |
| Landscape | 1 |
| League | 1 |
| Lipofibroblast | 1 |
| Lean | 1 |
| Lehtinen | 1 |
| Leite | 1 |
| Lessons | 1 |
| Let | 1 |
| Leyang | 1 |
| Libertés | 1 |
| Library | 1 |
| License | 1 |
| Licensure | 1 |
| Like | 1 |
| Lim | 1 |
| LH | 1 |
| LC | 1 |
| Kyung | 1 |
| Kruskal | 1 |
| Kalligeros | 1 |
| Kanakadurga | 1 |
| Karina | 1 |
| Karine | 1 |
| Kass | 1 |
| Katsahian | 1 |
| Kaufman | 1 |
| Kaushal | 1 |
| Kenneth | 1 |
| Kg | 1 |
| Kidney | 1 |
| Killer | 1 |
| Kinetics | 1 |
| King | 1 |
| Klebsiella | 1 |
| Knock | 1 |
| Kochhar | 1 |
| Kokkinos | 1 |
| Konstantinos | 1 |
| Koo | 1 |
| Korakas | 1 |
| Korean | 1 |
| Kountouri | 1 |
| Kousathana | 1 |
| Krawczyk | 1 |
| Lina | 1 |
| Lipolysis | 1 |
| IL-13Rα1 | 1 |
| Manager | 1 |
| MS | 1 |
| MYC | 1 |
| Mac | 1 |
| MacKenzie | 1 |
| Macartney | 1 |
| Macrophages | 1 |
| Madinah | 1 |
| Mai | 1 |
| Maine | 1 |
| Makkah | 1 |
| Mammalian | 1 |
| Manag | 1 |
| Manitoba | 1 |
| Lipopolysaccharide | 1 |
| Marcin | 1 |
| Marcio | 1 |
| Mariangela | 1 |
| Martine | 1 |
| Mask | 1 |
| Massiera | 1 |
| Maud | 1 |
| Mayo | 1 |
| McCartney | 1 |
| McGill | 1 |
| McGowan | 1 |
| McMaster | 1 |
| MRI | 1 |
| MOF | 1 |
| MNT | 1 |
| MIP-1a | 1 |
| Lipowska | 1 |
| Literature | 1 |
| Living | 1 |
| Load | 1 |
| Local | 1 |
| Lokken | 1 |
| Longgen | 1 |
| Longitudinal | 1 |
| Loozit | 1 |
| Los | 1 |
| Luca | 1 |
| Lucas | 1 |
| Luis | 1 |
| Luiz | 1 |
| Luiza | 1 |
| Lunchtime | 1 |
| Luzi | 1 |
| Lyn | 1 |
| M2 | 1 |
| MASP-2-mediated | 1 |
| MCTQ | 1 |
| MDSCs | 1 |
| MHC | 1 |
| MI | 1 |
| MIF | 1 |
| Kachikis | 1 |
| KP | 1 |
| KLF7 | 1 |
| Indications | 1 |
| Immunosuppression | 1 |
| Impairments | 1 |
| Implications | 1 |
| Impor- | 1 |
| Inadequacy | 1 |
| Inc. | 1 |
| Incentives | 1 |
| Incidence | 1 |
| Incident | 1 |
| Income | 1 |
| Indian | 1 |
| Indians | 1 |
| Indicator | 1 |
| Jørn | 1 |
| Indices | 1 |
| Induction | 1 |
| Infact | 1 |
| Infancy | 1 |
| Infarction | 1 |
| Influences | 1 |
| Informatics | 1 |
| Infuenza | 1 |
| Inguinal | 1 |
| Initial | 1 |
| Initiation | 1 |
| Innate | 1 |
| Immunopathogenesis | 1 |
| Immunomodulation | 1 |
| Immunology | 1 |
| Immigrants | 1 |
| IL-17 | 1 |
| IL-1β | 1 |
| IL-33 | 1 |
| IL-6-producing | 1 |
| IL-6R | 1 |
| IL10 | 1 |
| IL13ral | 1 |
| IL1β | 1 |
| IL6R | 1 |
| ILC2s | 1 |
| ILI | 1 |
| IL‐1β | 1 |
| IMP2 | 1 |
| IMT | 1 |
| INDIAB | 1 |
| INF | 1 |
| IUFD | 1 |
| Iba-1 | 1 |
| Identification | 1 |
| Identifier | 1 |
| Ieda | 1 |
| Ignatios | 1 |
| Ikonomidis | 1 |
| Il-1b | 1 |
| Illness | 1 |
| Inpatients | 1 |
| 1 | |
| Institutes | 1 |
| Jan | 1 |
| Janus | 1 |
| Jean | 1 |
| Jean‐Luc | 1 |
| Jean‐Sébastien | 1 |
| Jeffrey | 1 |
| Jennifer | 1 |
| Jeor | 1 |
| Jessica | 1 |
| Ji | 1 |
| Jian | 1 |
| Jie | 1 |
| Jildau | 1 |
| John | 1 |
| Johns | 1 |
| Jorg | 1 |
| Josep | 1 |
| José | 1 |
| Juan | 1 |
| Juliana | 1 |
| July | 1 |
| June | 1 |
| Jung | 1 |
| Junior | 1 |
| Juonala | 1 |
| Ekiz | 1 |
| Jannot | 1 |
| Jacobi | 1 |
| Institutional | 1 |
| Jacks | 1 |
| Intake | 1 |
| Interferons | 1 |
| Intergenic | 1 |
| Interleukin | 1 |
| Interleukin-10 | 1 |
| Intracellular | 1 |
| Investigators | 1 |
| Involvement | 1 |
| Iron | 1 |
| Islet | 1 |
| Issa | 1 |
| Italian | 1 |
| Italians | 1 |
| Itamar | 1 |
| Itrim | 1 |
| Ivan | 1 |
| Iwona | 1 |
| J.-C. | 1 |
| JACC | 1 |
| JBD | 1 |
| JIM | 1 |
| JLD | 1 |
| JSH | 1 |
| JUNE | 1 |
| JV | 1 |
| Elective | 1 |
| Condition | 1 |
| Eicosapentaenoic | 1 |
| B. | 1 |
| Atlas | 1 |
| Attainment | 1 |
| Attenuation | 1 |
| Aune | 1 |
| Author(s | 1 |
| Authority | 1 |
| Autonomic | 1 |
| Autopsy | 1 |
| Avivit | 1 |
| Axis | 1 |
| Azienda | 1 |
| Aziz | 1 |
| B12 | 1 |
| Anna | 1 |
| BANG | 1 |
| BMC | 1 |
| BMI<30 | 1 |
| BMI>30 | 1 |
| BMI>35 | 1 |
| BMI>40Kg | 1 |
| BMM | 1 |
| BMOD | 1 |
| BY | 1 |
| Background | 1 |
| Bacteriodetes | 1 |
| Balampanis | 1 |
| Atherosclerosis | 1 |
| Atherogenesis | 1 |
| Athanasios | 1 |
| Asthma | 1 |
| Anne | 1 |
| Anno | 1 |
| Annual | 1 |
| Anthropometric | 1 |
| Anthropometrical | 1 |
| Antimicrobial | 1 |
| Antonio | 1 |
| Apolipoprotein | 1 |
| Appendix | 1 |
| Appetitive | 1 |
| Application | 1 |
| Approaches | 1 |
| Appropriate | 1 |
| Argenziano | 1 |
| Arterburn | 1 |
| Artery | 1 |
| Arthrobacter | 1 |
| Artificial | 1 |
| Ash | 1 |
| Asia | 1 |
| Assays | 1 |
| Assoc | 1 |
| Associate | 1 |
| Associates | 1 |
| Associations | 1 |
| Ban | 1 |
| Band | 1 |
| Bao | 1 |
| Bo | 1 |
| Bogalusa | 1 |
| Boirie | 1 |
| Bone | 1 |
| Bornstein | 1 |
| Bos | 1 |
| Branch | 1 |
| Brazzi | 1 |
| Breeds | 1 |
| Brown | 1 |
| Brunault | 1 |
| Bud | 1 |
| Bureau | 1 |
| Busana | 1 |
| By | 1 |
| C. | 1 |
| C00 | 1 |
| C57BL/6 | 1 |
| C5aR1 | 1 |
| CATSS | 1 |
| CBT- | 1 |
| CCI | 1 |
| CCL14 | 1 |
| CCR2 | 1 |
| CD11c(+ | 1 |
| CD14 | 1 |
| Board | 1 |
| Blount | 1 |
| Barbara | 1 |
| Bloom | 1 |
| Baricitinib | 1 |
| Barlow | 1 |
| Barrès | 1 |
| Basis | 1 |
| Batterham | 1 |
| Beeker | 1 |
| Behavior | 1 |
| Behaviour | 1 |
| Bello | 1 |
| Beneficial | 1 |
| Benefit | 1 |
| Benjamin | 1 |
| Bhakti | 1 |
| Bhatraju | 1 |
| Biao | 1 |
| Bias | 1 |
| Bilal | 1 |
| Biochemistry | 1 |
| Biogenesis | 1 |
| Biological | 1 |
| Biomarkers | 1 |
| Bjorge | 1 |
| Blaak | 1 |
| Blockade | 1 |
| Blockers | 1 |
| Annals | 1 |
| Animal | 1 |
| CD16 | 1 |
| AG | 1 |
| 95th | 1 |
| A.D. | 1 |
| AAP | 1 |
| ABO | 1 |
| ACE)/ | 1 |
| ACE2-RAS | 1 |
| ACE2-directed | 1 |
| ACE2-knockout | 1 |
| ACEI | 1 |
| ADA | 1 |
| ADP | 1 |
| AF | 1 |
| AHA | 1 |
| Angiotensinogen | 1 |
| AHI | 1 |
| AHRQ | 1 |
| ALI | 1 |
| ALT | 1 |
| AM | 1 |
| AMA | 1 |
| AMOS | 1 |
| AMP | 1 |
| AMSTAR | 1 |
| ANR-11-LABX-0021-LipSTIC | 1 |
| APOE | 1 |
| APan | 1 |
| 68±14 | 1 |
| 67a536d75890f8ef549f9e0afe9feb7c7bd94de5 | 1 |
| 5b671e3f4674930993bae2461ee559b59c8e220f | 1 |
| 5L | 1 |
| Meals | 1 |
| -11 | 1 |
| -27.91 | 1 |
| -34 | 1 |
| -34.54 | 1 |
| -American | 1 |
| -COVID | 1 |
| -Hôpitaux | 1 |
| -Preliminary | 1 |
| -United | 1 |
| -calculated | 1 |
| -the | 1 |
| 002 | 1 |
| 0BH13EZ | 1 |
| 0d6a50ea587b5e917078213091c7fe64d8a603b3 | 1 |
| 10.1210 | 1 |
| 219df692a561a0aea437a4a5146eed5cd065e691 | 1 |
| 2f6878617d8b91035a1cf113d1058b73cf6591f7 | 1 |
| 3.0 | 1 |
| 3.6.5 | 1 |
| 35‐40 | 1 |
| 38±15 | 1 |
| 39·9 | 1 |
| 3dkl6iha | 1 |
| 4tw7kfek | 1 |
| APat | 1 |
| ARBs | 1 |
| AS1 | 1 |
| Agent | 1 |
| Aikaterini | 1 |
| Akhtar | 1 |
| Akirov | 1 |
| Alberti | 1 |
| Alcohol | 1 |
| Alexander | 1 |
| Alfaris | 1 |
| Alicja | 1 |
| Alisa | 1 |
| Almeida | 1 |
| Alqalhtani | 1 |
| Alternative | 1 |
| Am | 1 |
| Ameet | 1 |
| Ameliorates | 1 |
| Amiel | 1 |
| Amira | 1 |
| Amit | 1 |
| An | 1 |
| Ana | 1 |
| Anand | 1 |
| André | 1 |
| Angeles | 1 |
| Angiogenesis | 1 |
| Angiotensinconverting | 1 |
| Ages | 1 |
| Affairs | 1 |
| ASMBS | 1 |
| Advisory | 1 |
| AST | 1 |
| AT1 | 1 |
| AT1R | 1 |
| ATS | 1 |
| Abdulzahra | 1 |
| Ablation | 1 |
| Abstract | 1 |
| Abt | 1 |
| Acad | 1 |
| Access | 1 |
| Accumulation | 1 |
| Achilles | 1 |
| Actions | 1 |
| Active | 1 |
| Adams | 1 |
| Additional | 1 |
| Adenovirus | 1 |
| Adequacy | 1 |
| Adipocytokines | 1 |
| Adjunctive | 1 |
| Adjuvanted | 1 |
| Adolescents | 1 |
| Adulthood | 1 |
| Advers | 1 |
| Adverse | 1 |
| CD14+CD16 | 1 |
| CD17 | 1 |
| Egr1 | 1 |
| Darlenska | 1 |
| DEC | 1 |
| DH | 1 |
| DHD | 1 |
| DHHS | 1 |
| DPP | 1 |
| DPP-4 | 1 |
| DQ&A | 1 |
| Da | 1 |
| Dairy | 1 |
| Daniel | 1 |
| Danone | 1 |
| Dao | 1 |
| Darling | 1 |
| Concepción‐Urteaga | 1 |
| Database | 1 |
| Dawen | 1 |
| Dear | 1 |
| Deaths | 1 |
| Definition | 1 |
| Degree | 1 |
| Deierlein | 1 |
| Delaware | 1 |
| Density | 1 |
| Deposition | 1 |
| Depression | 1 |
| Detecting | 1 |
| DEBQ | 1 |
| DEA | 1 |
| D48 | 1 |
| D3 | 1 |
| Conclusion | 1 |
| Conditions | 1 |
| Conference | 1 |
| Connect | 1 |
| Constitution | 1 |
| Contini | 1 |
| Cooperative | 1 |
| Coronado‐Arroyo | 1 |
| Coronary | 1 |
| Coronaviridae | 1 |
| Coronavirus-2 | 1 |
| Correlates | 1 |
| Cost | 1 |
| Cotran | 1 |
| Course | 1 |
| Cov2 | 1 |
| Covid‐19 | 1 |
| Coxson | 1 |
| Cristina | 1 |
| Crowl | 1 |
| Cryo | 1 |
| Ct | 1 |
| Cueto | 1 |
| Current | 1 |
| Cyclooxygenase-2 | 1 |
| Determining | 1 |
| Di | 1 |
| Diabetic | 1 |
| E6617 | 1 |
| E6627 | 1 |
| E6686 | 1 |
| E6687 | 1 |
| E6696 | 1 |
| E6697 | 1 |
| E78 | 1 |
| EASL | 1 |
| EBT | 1 |
| ECON | 1 |
| EG | 1 |
| EL | 1 |
| ELISA | 1 |
| EM | 1 |
| EMAS | 1 |
| EQ-5D | 1 |
| ERV | 1 |
| ESPEN | 1 |
| ET-1 | 1 |
| Eckel | 1 |
| Ectopic | 1 |
| Eculizumab | 1 |
| Edition | 1 |
| Editor | 1 |
| Efeitos | 1 |
| Efficacy | 1 |
| E6626 | 1 |
| E6616 | 1 |
| Diehl | 1 |
| E6607 | 1 |
| Dietitian | 1 |
| Differences | 1 |
| Differential | 1 |
| Dimensions | 1 |
| Dipeptidyl | 1 |
| Disabilities | 1 |
| Discovery | 1 |
| Disinhibited | 1 |
| Dixon | 1 |
| Dobrowolska | 1 |
| Domain | 1 |
| Dominique | 1 |
| Dong | 1 |
| Donor | 1 |
| Downregulation | 1 |
| Drive | 1 |
| Drugs | 1 |
| Dyslipidemias | 1 |
| Dysregulation | 1 |
| D’Amato | 1 |
| E11 | 1 |
| E2 | 1 |
| E43 | 1 |
| E46 | 1 |
| E6606 | 1 |
| Concern | 1 |
| Comprehensive | 1 |
| CD25 | 1 |
| Cardiorespiratory | 1 |
| CXC | 1 |
| CXCL10 | 1 |
| Cabrera | 1 |
| Cahn | 1 |
| Caironi | 1 |
| Calif | 1 |
| Campinas | 1 |
| Camporota | 1 |
| Canadian | 1 |
| Cardiac | 1 |
| Cardiology | 1 |
| Cardiomyopathy | 1 |
| Cardiothoracic | 1 |
| Component | 1 |
| Cardiovasc | 1 |
| Cards | 1 |
| Carel | 1 |
| Carette | 1 |
| Carlos | 1 |
| Caseload | 1 |
| Caucasians | 1 |
| Cdr1as | 1 |
| Cell | 1 |
| Centre | 1 |
| Cepheid | 1 |
| Certain | 1 |
| CWR | 1 |
| CSF+ | 1 |
| CSF | 1 |
| CRL | 1 |
| CD3 | 1 |
| CD36 | 1 |
| CD86 | 1 |
| CD8ϩ | 1 |
| CDKN2A | 1 |
| CDKN2B | 1 |
| CDR42020182189 | 1 |
| CE | 1 |
| CHES | 1 |
| CITY | 1 |
| CNIL | 1 |
| CO2 | 1 |
| CONSTANCES | 1 |
| COR | 1 |
| COVID- | 1 |
| COVID-19-Associated | 1 |
| COVID-19-Related | 1 |
| COVID-19-induced | 1 |
| COVID-19.Obesity | 1 |
| COVID-2019 | 1 |
| COVID-307 | 1 |
| COVID-348 | 1 |
| COllaborative | 1 |
| CPP32 | 1 |
| CREB | 1 |
| Cervical | 1 |
| Chamseddine | 1 |
| Chan | 1 |
| Claudia | 1 |
| Clinic | 1 |
| ClinicalTrials.gov | 1 |
| Closings | 1 |
| Co | 1 |
| CoA | 1 |
| CoLaus | 1 |
| CoV-2-induced | 1 |
| CoV. | 1 |
| CoV13 | 1 |
| CoV34 | 1 |
| CoVID-19 | 1 |
| Coagulopathy | 1 |
| Coalition | 1 |
| Cobas | 1 |
| Coding | 1 |
| Cold | 1 |
| Collaborative | 1 |
| Collision | 1 |
| Colombera | 1 |
| Comment | 1 |
| Communication | 1 |
| Community | 1 |
| Comparative | 1 |
| Comparação | 1 |
| Compartment | 1 |
| Clearance | 1 |
| Classroom | 1 |
| Chandrasekaran | 1 |
| Classes | 1 |
| Chang | 1 |
| Change | 1 |
| Changes | 1 |
| Chao | 1 |
| Characterization | 1 |
| Chavolla | 1 |
| Cheng | 1 |
| Chengdu | 1 |
| Chiarito | 1 |
| Chigr | 1 |
| Chiumello | 1 |
| Choose | 1 |
| ChooseMy-Plate.gov | 1 |
| Christian | 1 |
| Christie | 1 |
| Christopher | 1 |
| Chronotype | 1 |
| Chuanwu | 1 |
| Chunyang | 1 |
| Church | 1 |
| CircPABPN1 | 1 |
| CircSLNN | 1 |
| Circumference | 1 |
| Cisanello | 1 |
| Class | 1 |
| Meal | 1 |
| Warehouse | 1 |
| Measurements | 1 |
| anterior | 1 |
| a870fd0f03067e9ee1a3ec93925aae2850217e06 | 1 |
| accelerometry | 1 |
| action/ | 1 |
| adipocytes | 1 |
| adipose | 1 |
| adolescentes | 1 |
| ageusia | 1 |
| alpha | 1 |
| analysos | 1 |
| angiotensin | 1 |
| angiotensin-(1 | 1 |
| ankyrin | 1 |
| antiphospholipid | 1 |
| board | 1 |
| antisense | 1 |
| arterivirus | 1 |
| arthrosis | 1 |
| atherogenesis | 1 |
| author(s | 1 |
| azithromycin | 1 |
| b8b883b8072f451bd155790807b91211e459c80f | 1 |
| bacteroidetes | 1 |
| baricitinib | 1 |
| behav | 1 |
| biobank | 1 |
| bioclinical | 1 |
| a02tueuu | 1 |
| Zooming | 1 |
| Zone | 1 |
| Zimmet | 1 |
| Ximena | 1 |
| Xinying | 1 |
| Xu | 1 |
| Xuebing | 1 |
| Y. | 1 |
| YUM | 1 |
| Yac | 1 |
| Yak | 1 |
| Yan | 1 |
| Yang | 1 |
| Yates | 1 |
| Years | 1 |
| Yende | 1 |
| Yi | 1 |
| Yki | 1 |
| YouTube | 1 |
| Yumuk | 1 |
| Yun | 1 |
| Yuxin | 1 |
| Yves | 1 |
| Zaiou | 1 |
| Zavaleta‐Gutiérrez | 1 |
| Zawada | 1 |
| Zhaoping | 1 |
| Ziegler | 1 |
| biomedicine | 1 |
| bolic | 1 |
| Measuring | 1 |
| cord-351223-nnuoadh6 | 1 |
| cobas | 1 |
| cohort | 1 |
| cord-011333-yyhwtnza | 1 |
| cord-266380-lu6hj3a2 | 1 |
| cord-277074 | 1 |
| cord-277803 | 1 |
| cord-288255-p8uzrsbd | 1 |
| cord-291627 | 1 |
| cord-311535-ppkwd1kp | 1 |
| cord-318391 | 1 |
| cord-319580-awtp0mpg | 1 |
| cord-321997 | 1 |
| cord-354805 | 1 |
| box | 1 |
| coronaviruses | 1 |
| crescimento | 1 |
| crown-152 | 1 |
| cyclic | 1 |
| cystectomy | 1 |
| cytokinic | 1 |
| cytomegalovirus | 1 |
| cytotropic | 1 |
| del | 1 |
| des | 1 |
| diabetes | 1 |
| diabetes-5-year | 1 |
| clinicopathological | 1 |
| circTshz2 | 1 |
| circSRY | 1 |
| circRNA_26852 | 1 |
| bqaa154 | 1 |
| brliql4d | 1 |
| c2605ddae1688b39797a8ed57c6a961547c91478 | 1 |
| c6ddfda76387c8adf1be3af836126a2785de59e5 | 1 |
| c6f39b4038a5ca389045593a390dd71fc7a5daef | 1 |
| c7c8eab93260ff21bfd57f098e9de51188bcb92c | 1 |
| case | 1 |
| caspase-3 | 1 |
| cells9061473 | 1 |
| changeÀ | 1 |
| chemerin | 1 |
| chi | 1 |
| chole | 1 |
| chorda | 1 |
| ciRS-133 | 1 |
| cingulate | 1 |
| circEIF3J | 1 |
| circFUT10 | 1 |
| circFoxo3 | 1 |
| circPABPN1 | 1 |
| circPAIP2 | 1 |
| circPan3 | 1 |
| circRNA9227 | 1 |
| circRNA_0046367 | 1 |
| circRNA_11897 | 1 |
| Xiang‐an | 1 |
| Xbox | 1 |
| XENDOS | 1 |
| U1 | 1 |
| Tracheal | 1 |
| Traditional | 1 |
| Transfer | 1 |
| Translating | 1 |
| TranslationLab | 1 |
| Transtheoretical | 1 |
| TriNetX. | 1 |
| Trilogy | 1 |
| Twenty | 1 |
| Twig | 1 |
| Twins | 1 |
| Types | 1 |
| UCP1 | 1 |
| WuHan | 1 |
| UKOSS | 1 |
| UKPDS | 1 |
| UN | 1 |
| Uberto | 1 |
| Ucp1 | 1 |
| Ued | 1 |
| Ultra | 1 |
| Ultrasonographic | 1 |
| Unconventional | 1 |
| Understanding | 1 |
| Unicamp | 1 |
| Unifesp | 1 |
| Trachea | 1 |
| Total | 1 |
| Toll | 1 |
| Time | 1 |
| TRL-4 | 1 |
| TSH | 1 |
| Takotsubo | 1 |
| Tan | 1 |
| Tanner | 1 |
| Targets | 1 |
| Taskforce | 1 |
| Taxonomy | 1 |
| Technology | 1 |
| Teens | 1 |
| Telehealth | 1 |
| Telemedicine | 1 |
| Teodora | 1 |
| Test | 1 |
| Th22 | 1 |
| Th7 | 1 |
| Ther | 1 |
| Therapeutics | 1 |
| Therapies | 1 |
| Thompson | 1 |
| Thorkild | 1 |
| Thromboembolism | 1 |
| Thrombosis | 1 |
| Tianmin | 1 |
| Tigran | 1 |
| Units | 1 |
| Universidade | 1 |
| Universitaria | 1 |
| Volumetrics | 1 |
| WA | 1 |
| WHOQOL | 1 |
| WW | 1 |
| WWW | 1 |
| Waldorf | 1 |
| Walker | 1 |
| Walking | 1 |
| Wallis | 1 |
| Warburg | 1 |
| Wei | 1 |
| Well | 1 |
| Wellcome | 1 |
| Wennberg | 1 |
| Wenzhou | 1 |
| Whitehall | 1 |
| Wide | 1 |
| Widespread | 1 |
| Wii | 1 |
| WiiU | 1 |
| Wilfley | 1 |
| Windsor | 1 |
| Wordsworth | 1 |
| Workshop | 1 |
| Worldwide | 1 |
| Wright | 1 |
| W | 1 |
| Volkan | 1 |
| Universities | 1 |
| Vivo | 1 |
| Upregulation | 1 |
| User | 1 |
| V | 1 |
| VAS | 1 |
| VIP | 1 |
| VS | 1 |
| VTE | 1 |
| Vaccine | 1 |
| Vaia | 1 |
| Valsartan | 1 |
| Van | 1 |
| Vanstapel | 1 |
| Variation | 1 |
| Vasas | 1 |
| Vasc | 1 |
| Vasculature | 1 |
| Veesler | 1 |
| Velicu | 1 |
| Venous | 1 |
| Venturi | 1 |
| Veterans | 1 |
| Vidal | 1 |
| Video | 1 |
| Viruses | 1 |
| Vitro | 1 |
| diferential | 1 |
| disease-2019 | 1 |
| docosahexaenoic | 1 |
| regression | 1 |
| post | 1 |
| protein | 1 |
| protein-1α | 1 |
| protocadherin | 1 |
| pwbzffo9 | 1 |
| quinapril | 1 |
| rRNA | 1 |
| rRNAs | 1 |
| randomeffects | 1 |
| receptor-1 | 1 |
| receptor-4 | 1 |
| region----case | 1 |
| research | 1 |
| novel_circ_0010775 | 1 |
| reserve | 1 |
| resistin | 1 |
| rhinosinusitis | 1 |
| risk;(2 | 1 |
| ritonavir | 1 |
| riu4jdc2 | 1 |
| ro041w5l | 1 |
| rosuvastatin | 1 |
| ruxolitinib | 1 |
| s12519 | 1 |
| sHLH | 1 |
| santé | 1 |
| pneumoperitoneum | 1 |
| pneumo | 1 |
| plasma | 1 |
| piriform | 1 |
| novo | 1 |
| ns | 1 |
| obesities | 1 |
| obesityinduced | 1 |
| obesos | 1 |
| oby.22941 | 1 |
| oby.23027 | 1 |
| olmesartan | 1 |
| omics | 1 |
| openaccess | 1 |
| operations | 1 |
| orbitofrontal | 1 |
| oreos | 1 |
| owner(s | 1 |
| p=0 | 1 |
| p=0.029 | 1 |
| pathogendriven | 1 |
| patients | 1 |
| patientswith | 1 |
| perfis | 1 |
| perilipin-2 | 1 |
| pescadillo | 1 |
| phentermine | 1 |
| phenterminetopiramate | 1 |
| piRNAs | 1 |
| sapid | 1 |
| sarcopenic | 1 |
| saxagliptin | 1 |
| vaso | 1 |
| ventilation | 1 |
| vi | 1 |
| vildagliptin | 1 |
| waist‐height | 1 |
| work | 1 |
| www | 1 |
| www.icnarc.og | 1 |
| youth | 1 |
| zinco | 1 |
| © | 1 |
| ® | 1 |
| ° | 1 |
| α-2b | 1 |
| Ͻ30 | 1 |
| Ͼ35 | 1 |
| †Asthma | 1 |
| ‡ | 1 |
| ↓cardiac | 1 |
| ↓functional | 1 |
| ↓lung | 1 |
| ↓tissue | 1 |
| ≤ | 1 |
| | 1 |
| | 1 |
| 60 | 1 |
| vational | 1 |
| type-2 | 1 |
| series-2 | 1 |
| tympani | 1 |
| series-3 | 1 |
| series-4 | 1 |
| series-5 | 1 |
| sirtuin | 1 |
| snRNAs | 1 |
| sobre | 1 |
| solitaris | 1 |
| square | 1 |
| st | 1 |
| statistique | 1 |
| stod75j2 | 1 |
| subfamily | 1 |
| subjectivité | 1 |
| tRNAs | 1 |
| tachypnea | 1 |
| teenlongitudinal | 1 |
| tele | 1 |
| thalamus | 1 |
| thrombogenic | 1 |
| todb1d4x | 1 |
| tractus | 1 |
| trans | 1 |
| transcriptomes | 1 |
| transpeptidase | 1 |
| trastornos | 1 |
| novel_circ_0011513 | 1 |
| novel_circ_0009127 | 1 |
| drug(s | 1 |
| imune | 1 |
| hematogenous | 1 |
| hematosis | 1 |
| highdose | 1 |
| homologue | 1 |
| hsa | 1 |
| hsa_circ_0004846 | 1 |
| https://www.crd.york | 1 |
| https://www.frontiersin.org/articles/10.3389/fendo | 1 |
| hyper)inflammation | 1 |
| hyperinsulinemic | 1 |
| hyperplasic | 1 |
| immunosenescence | 1 |
| imunológico | 1 |
| novel_circ_0006981 | 1 |
| indicadores | 1 |
| inmune | 1 |
| institutional | 1 |
| insula | 1 |
| interferon | 1 |
| interleukin-1β | 1 |
| interleukin-4 | 1 |
| interleukin-5 | 1 |
| interleukine-6 | 1 |
| intervention(s | 1 |
| intranasal | 1 |
| ionophores | 1 |
| hDPP4-transgenic | 1 |
| grunniens | 1 |
| glycan | 1 |
| glycaemia | 1 |
| e4 | 1 |
| e7daa048ff3496a7775181e89829a8cb778614ac | 1 |
| east | 1 |
| egressos | 1 |
| ehealth | 1 |
| electro | 1 |
| endocr | 1 |
| endosomal | 1 |
| energy | 1 |
| entre | 1 |
| epigenomic | 1 |
| epigenomics | 1 |
| euglycemic | 1 |
| examin | 1 |
| expenditure | 1 |
| expert | 1 |
| fat | 1 |
| fibrinolysis | 1 |
| fibrosis-4 | 1 |
| fluoro | 1 |
| forkhead | 1 |
| geroscience | 1 |
| glicêmico | 1 |
| glomerulomegaly | 1 |
| glomerulosclerosis | 1 |
| iorsÀi.e | 1 |
| j.acap.2020.08.010 | 1 |
| j.cppeds.2020.100871 | 1 |
| miR-103 | 1 |
| miR-143 | 1 |
| miR-155 | 1 |
| miR-33 | 1 |
| miR-34a | 1 |
| miR-652 | 1 |
| mice | 1 |
| microthrombi | 1 |
| mm | 1 |
| monoallelic | 1 |
| myofibroblast | 1 |
| myogenic | 1 |
| méthodologique | 1 |
| n=2004 | 1 |
| n=5879 | 1 |
| n=6437 | 1 |
| n=9769 | 1 |